IN-VITRO SUSCEPTIBILITY OF ATYPICAL MYCOBACTERIA TO RIFAMPIN

被引：10

作者：

MOLAVI, A

WEINSTEIN, L

机构：

来源：

APPLIED MICROBIOLOGY | 1971年 / 22卷 / 01期

关键词：

D O I：

10.1128/AEM.22.1.23-25.1971

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：23 / +

页数：1

共 15 条

[1] LABORATORY AND CLINICAL EVALUATION OF RIFAMPICIN [J].

ATLAS, E ;

TURCK, M .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1968, 256 (04) :247-&

[2]

CANETTI G, 1963, Rev Tuberc Pneumol (Paris), V27, P217

[3]

Clark J, 1967, Tubercle, V48, P144, DOI 10.1016/S0041-3879(67)80009-6

[4] RIFAMPIN - ANTIBACTERIAL ACTIVITY IN-VITRO AND ABSORPTION AND EXCRETION IN NORMAL YOUNG MEN [J].

DANS, PE ;

MCGEHEE, RF ;

WILCOX, C .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1970, 259 (02) :120-+

[5]

ENGBAEK HC, 1970, SCAND J RESPIR DIS, V51, P11

[6]

FURESZ S, 1967, ARZNEI-FORSCHUNG, V17, P534

[7]

GYSELEN A, 1968, AM REV RESPIR DIS, V98, P933

[8]

HOBBY GL, 1969, P SOC EXP BIOL MED, V131, P323, DOI 10.3181/00379727-131-33868

[9] IN VITRO EFFECT OF RIFAMPIN ON MYCOBACTERIA [J].

LORIAN, V ;

FINLAND, M .

APPLIED MICROBIOLOGY, 1969, 17 (02) :202-&

[10] RIFAMPICIN - A NEW ORALLY ACTIVE RIFAMYCIN [J].

MAGGI, N ;

PASQUALUCCI, CR ;

BALLOTTA, R ;

SENSI, P .

CHEMOTHERAPY, 1966, 11 (05) :285-+

← 1 2 →